Showing results (161-170 of 279) with videos related to
Sort By:
Pageof 28
Blood|December 25, 2013
IKZF1 status as a prognostic feature in BCR-ABL1-positive childhood ALLArian van der Veer, Marketa Zaliova, Federica Mottadelli, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2004
Increasing mixed chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell transplantation: possible role for pre-emptive immunotherapy?Peter Bader, Hermann Kreyenberg, Walter Hoelle, et al.British Journal of Haematology|January 14, 2010
Prognostic relevance of dic(9;20)(p11;q13) in childhood B-cell precursor acute lymphoblastic leukaemia treated with Berlin-Frankfurt-Münster (BFM) protocols containing an intensive induction and post-induction consolidation therapyHerbert Pichler, Anja Möricke, Georg Mann, et al.Blood Cancer Journal|June 28, 2020
Repurposing anthelmintic agents to eradicate resistant leukemiaCaterina Mezzatesta, Liridon Abduli, Anna Guinot, et al.European Journal of Cancer (Oxford, England : 1990)|September 16, 2022
Near-tetraploid T-cell acute lymphoblastic leukaemia in childhood: Results of the AIEOP-BFM ALL studiesFrancesco Ceppi, Giacomo Gotti, Anja Möricke, et al.BMC Genomic Data|April 19, 2022
An alternative CYB5A transcript is expressed in aneuploid ALL and enriched in relapseLorenz Bartsch, Michael P Schroeder, Sonja Hänzelmann, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2019
Outcome of Children With Hypodiploid Acute Lymphoblastic Leukemia: A Retrospective Multinational StudyChing-Hon Pui, Paola Rebora, Martin Schrappe, et al.JNCI Cancer Spectrum|July 31, 2019
Validation of Minimal Residual Disease as Surrogate Endpoint for Event-Free Survival in Childhood Acute Lymphoblastic LeukemiaStefania Galimberti, Meenakshi Devidas, Ausiliatrice Lucenti, et al.Genes, Chromosomes & Cancer|January 22, 2014
Recurrent mutation of JAK3 in T-cell prolymphocytic leukemiaAnke K Bergmann, Sina Schneppenheim, Marc Seifert, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2015
Monitoring of minimal residual disease after allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia allows for the identification of impending relapse: results of the ALL-BFM-SCT 2003 trialPeter Bader, Hermann Kreyenberg, Arend von Stackelberg, et al.Pageof 28